Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
1.03
Dollar change
+0.02
Percentage change
1.98
%
Index- P/E- EPS (ttm)-2.17 Insider Own3.20% Shs Outstand10.04M Perf Week0.00%
Market Cap10.34M Forward P/E- EPS next Y- Insider Trans-5.75% Shs Float9.72M Perf Month1.98%
Income-19.09M PEG- EPS next Q-0.31 Inst Own8.34% Short Float1.39% Perf Quarter-10.43%
Sales0.24M P/S43.09 EPS this Y- Inst Trans0.45% Short Ratio1.08 Perf Half Y-20.16%
Book/sh0.63 P/B1.64 EPS next Y- ROA-112.40% Short Interest0.14M Perf Year-52.97%
Cash/sh0.53 P/C1.95 EPS next 5Y- ROE-134.07% 52W Range0.89 - 2.33 Perf YTD-7.21%
Dividend Est.- P/FCF- EPS past 5Y20.91% ROI-265.77% 52W High-55.79% Beta0.90
Dividend TTM- Quick Ratio3.67 Sales past 5Y-47.43% Gross Margin-10.74% 52W Low15.59% ATR (14)0.07
Dividend Ex-Date- Current Ratio3.67 EPS Y/Y TTM-61.52% Oper. Margin-8169.01% RSI (14)50.18 Volatility8.41% 6.36%
Employees24 Debt/Eq0.24 Sales Y/Y TTM-85.83% Profit Margin-7886.36% Recom3.00 Target Price30.00
Option/ShortYes / Yes LT Debt/Eq0.16 EPS Q/Q-5.55% Payout- Rel Volume0.32 Prev Close1.01
Sales Surprise- EPS Surprise- Sales Q/Q-96.18% Earnings- Avg Volume125.70K Price1.03
SMA200.24% SMA500.73% SMA200-20.02% Trades Volume40,320 Change1.98%
Date Action Analyst Rating Change Price Target Change
Dec-13-18Initiated H.C. Wainwright Buy $2.50
Nov-10-17Downgrade Raymond James Outperform → Mkt Perform
Jan-25-17Initiated Raymond James Outperform
Aug-11-15Downgrade Cantor Fitzgerald Buy → Hold
Jun-29-15Initiated Piper Jaffray Overweight $5
Jun-29-15Initiated Jefferies Buy $5
Feb-08-24 05:52PM
Jan-25-24 08:05AM
Jan-09-24 08:05AM
Dec-06-23 08:05AM
Nov-13-23 08:05AM
05:08AM Loading…
Nov-10-23 05:08AM
Nov-08-23 08:05AM
Oct-10-23 07:18AM
Sep-08-23 12:46PM
Aug-25-23 07:36PM
Aug-23-23 08:05AM
Jul-12-23 03:01AM
May-25-23 10:49AM
Mar-21-23 08:05AM
Feb-10-23 05:12AM
08:05AM Loading…
Nov-15-22 08:05AM
Sep-06-22 08:20AM
08:05AM
Jul-08-22 08:05AM
May-17-22 08:05AM
Mar-03-22 10:13PM
Mar-01-22 08:05AM
Feb-23-22 08:05AM
Feb-18-22 04:00PM
01:00PM
Feb-12-22 02:09PM
Feb-04-22 10:11AM
Feb-02-22 12:00PM
Jan-21-22 11:37AM
Jan-10-22 12:00PM
09:24AM Loading…
Dec-30-21 09:24AM
Nov-30-21 08:05AM
Sep-17-21 04:10PM
Jun-22-21 10:17AM
Jun-15-21 11:38AM
Mar-02-21 08:05AM
Feb-07-21 09:19AM
Sep-03-20 04:05PM
Aug-17-20 08:05AM
Jun-10-20 03:43PM
Apr-08-20 10:32AM
07:53AM
Apr-07-20 04:12PM
Apr-02-20 08:00AM
Mar-31-20 06:30PM
03:25PM
Mar-28-20 02:27PM
Mar-27-20 04:05PM
Mar-23-20 03:30PM
Mar-19-20 02:36PM
Feb-26-20 08:30AM
Jan-21-20 07:00AM
Jan-07-20 08:00AM
Dec-17-19 07:03PM
Dec-16-19 07:00AM
Nov-21-19 07:19AM
Nov-18-19 09:18AM
Nov-15-19 07:06AM
Nov-07-19 10:30AM
Oct-03-19 07:34AM
Oct-02-19 07:31PM
Sep-11-19 01:29PM
Sep-06-19 09:36AM
Aug-08-19 08:50PM
Aug-07-19 09:00AM
Aug-01-19 10:32AM
Jul-18-19 08:05AM
Jul-09-19 02:59PM
Jul-08-19 08:05AM
Jun-26-19 06:57AM
Jun-25-19 08:37AM
Jun-13-19 08:05AM
Jun-10-19 12:36PM
Jun-05-19 01:16AM
May-30-19 08:05AM
May-24-19 07:44AM
May-22-19 04:05PM
May-17-19 08:05AM
Apr-26-19 01:01PM
Apr-17-19 08:05AM
Mar-14-19 08:05AM
Feb-20-19 08:05AM
Feb-13-19 03:29AM
Feb-12-19 07:45AM
Feb-08-19 02:35PM
Feb-07-19 06:40PM
05:35PM
04:05PM
Jan-31-19 10:31AM
Jan-22-19 10:57AM
Jan-17-19 08:05AM
Dec-06-18 08:05AM
Dec-04-18 06:19PM
Nov-12-18 08:05AM
Nov-08-18 07:30PM
06:27PM
04:05PM
07:57AM
Oct-18-18 08:05AM
Oct-17-18 07:30AM
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gobel DavidDirectorNov 15 '23Sale1.6219,60731,7500Nov 17 06:34 PM